Home healthcare provider Addus HomeCare (NASDAQ:ADUS) in Q4 CY2025, with sales up 25.6% year on year to $373.1 million. Its non-GAAP profit of $1.77 per share was 2.6% above analysts’ consensus ...
Addus HomeCare faces regulatory risks, particularly from the Medicaid Access Rule, which could impact margins if 80% of funds must be spent on compensation. Managed Care Organization mix is rising, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results